▼ SELL
10b5-1 Plan
$ Value
$227K
Shares
3,162
Price
$72
Filed
Mar 13
Insider
Name
Mutz Christopher
Title
HEAD OF RARE DISEASE
CIK
0001846487
Roles
Officer
Transaction Details
Transaction Date
2026-03-13
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
91,309
Footnotes
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025. | The shares were sold in multiple trades at prices ranging from $70.27 to $72.62. The price reported above reflects the weighted average sales price.
Filing Info
Mutz Christopher's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-13 | ANIP | ▼ | $227K |
| 2026-03-09 | ANIP | ▼ | $267K |
| 2026-03-07 | ANIP | F | $245K |
| 2026-03-06 | ANIP | ▼ | $157K |
| 2026-03-02 | ANIP | ▼ | $31K |
| 2026-02-28 | ANIP | F | $164K |
| 2026-02-26 | ANIP | A | $1.6M |
| 2026-02-20 | ANIP | ▼ | $415K |
| 2026-02-14 | ANIP | F | $186K |
| 2026-02-12 | ANIP | F | $243K |
Other Insiders at ANIP (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Rowland Thomas Andrew
SVP, HEAD - ESTABLISHED BRANDS
|
— | $357K | 2026-03-11 |
|
CAREY STEPHEN P.
SVP & CFO
|
— | $552K | 2026-03-07 |
| Walsh Patrick D | — | $445K | 2026-03-03 |
|
Lalwani Nikhil
PRESIDENT & CEO
|
— | — | 2026-03-07 |
|
Gutwerg Ori
SVP, GENERICS
|
— | $158K | 2026-03-07 |
|
Mutz Christopher
HEAD OF RARE DISEASE
|
— | $1.4M | 2026-03-09 |
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
|
— | — | 2026-02-26 |
|
Gassert Chad
SVP - CORP. DEV. & STRATEGY
|
— | — | 2026-02-28 |
|
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
|
— | $114K | 2026-04-13 |
|
Davis Krista
SVP, CHIEF HR OFFICER
|
— | $785K | 2026-03-09 |